Table 4.
Treatment group | RT | FT | FT + ISBS | P α | P β | P γ |
---|---|---|---|---|---|---|
Operative time, h | 2.8 ± 0.7 | 3.0 ± 1.1 | 2.9 ± 0.9 | NS | NS | NS |
Blood loss, ml | 95.0 ± 40.5 | 100.5 ± 35.5 | 80.5 ± 32.5 | NS | NS | NS |
Volume of blood autotransfused (ml) | 0 | 0 | 500.2 ± 160.5 | / | / | / |
Conversion to open, n (n%) | 2 (3.7%) | 0 | 1 (3.6%) | NS | NS | NS |
Complications | ||||||
Postoperative fever (>38.5 °C), n (n%) | 9 (16.7%) | 4 (12.1%) | 5 (17.9%) | NS | NS | NS |
Others, n (n%) | 4 (7.4%) | 2 (6.0%) | 1 (3.61%) | NS | NS | NS |
Others including pulmonary infection, tender pancreatic leakage, subphrenic abscess, injure of colon.
Pα FT group comparring to TR group, < 0.05 has statistical significance*;
PβFT + ISBS group comparring to RT group, < 0.05 has statistical significance†;
PγFT + ISBS group comparring to FT group, < 0.05 has statistical significance§.